Compare Stocks: SKIN, ACRL, REVB, and CRL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRL Charles River Laboratories International	$290.32 +1.2%	$277.46	$146.20 ▼ $303.30	$13.85B	1.4	923,493 shs	443,549 shs
REVB Revelation Biosciences	$0.76 -4.7%	$1.00	$0.76 ▼ $6.76	$3.04M	-0.07	29,322 shs	43,894 shs
SKIN Beauty Health	$0.63	$0.67	$0.55 ▼ $1.76	$81.99M	1.05	299,266 shs	169,826 shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRL Charles River Laboratories International	0.00%	-0.74%	-0.98%	+25.90%	+70.36%
REVB Revelation Biosciences	0.00%	-12.25%	-24.40%	-29.30%	-86.92%
SKIN Beauty Health	0.00%	-5.23%	-9.61%	-13.20%	-64.51%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CRL Charles River Laboratories International	$290.32 +1.2%	$277.46	$146.20 ▼ $303.30	$13.85B	1.4	923,493 shs	443,549 shs
REVB Revelation Biosciences	$0.76 -4.7%	$1.00	$0.76 ▼ $6.76	$3.04M	-0.07	29,322 shs	43,894 shs
SKIN Beauty Health	$0.63	$0.67	$0.55 ▼ $1.76	$81.99M	1.05	299,266 shs	169,826 shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CRL Charles River Laboratories International	0.00%	-0.74%	-0.98%	+25.90%	+70.36%
REVB Revelation Biosciences	0.00%	-12.25%	-24.40%	-29.30%	-86.92%
SKIN Beauty Health	0.00%	-5.23%	-9.61%	-13.20%	-64.51%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CRL Charles River Laboratories International	2.82	Moderate Buy	$300.11	3.37% Upside
REVB Revelation Biosciences	1.00	Sell	N/A	N/A
SKIN Beauty Health	2.00	Hold	$1.38	118.25% Upside

Current Analyst Ratings Breakdown

Latest SKIN, ACRL, REVB, and CRL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/30/2026	CRL Charles River Laboratories International	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$357.00
9/30/2026	CRL Charles River Laboratories International	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/29/2026	REVB Revelation Biosciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
9/28/2026	CRL Charles River Laboratories International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/28/2026	CRL Charles River Laboratories International	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$305.00 ➝ $340.00
9/25/2026	CRL Charles River Laboratories International	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$300.00 ➝ $320.00
9/25/2026	CRL Charles River Laboratories International	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$330.00
9/25/2026	CRL Charles River Laboratories International	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$300.00 ➝ $325.00
9/25/2026	CRL Charles River Laboratories International	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$300.00 ➝ $330.00
9/25/2026	CRL Charles River Laboratories International	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$282.00 ➝ $322.00
9/25/2026	CRL Charles River Laboratories International	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$264.00 ➝ $295.00

(Data available from 10/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CRL Charles River Laboratories International	$4.02B	3.45	$21.96 per share	13.22	$64.39 per share	4.51
REVB Revelation Biosciences	N/A	N/A	N/A	N/A	$1.28 per share	N/A
SKIN Beauty Health	$300.80M	0.27	$0.15 per share	4.12	$0.48 per share	1.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CRL Charles River Laboratories International	-$144.34M	-$4.85	N/A	22.99	2.70	-5.96%	15.75%	6.51%	11/4/2026 (Estimated)
REVB Revelation Biosciences	-$8.91M	-$12.31	N/A	N/A	N/A	N/A	-100.19%	-82.72%	11/5/2026 (Estimated)
SKIN Beauty Health	-$9.52M	-$0.22	N/A	N/A	N/A	-9.79%	-47.83%	-5.79%	11/5/2026 (Estimated)

Latest SKIN, ACRL, REVB, and CRL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	REVB Revelation Biosciences	-$0.8750	-$0.87	+$0.0050	-$0.87	N/A	N/A
8/6/2026	Q2 2026	SKIN Beauty Health	-$0.0250	-$0.02	+$0.0050	-$0.02	$74.45 million	$72.11 million
8/5/2026	Q2 2026	CRL Charles River Laboratories International	$2.77	$3.02	+$0.25	-$0.03	$980.53 million	$1.00 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CRL Charles River Laboratories International	N/A	N/A	N/A	N/A	N/A
REVB Revelation Biosciences	N/A	N/A	N/A	N/A	N/A
SKIN Beauty Health	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CRL Charles River Laboratories International	0.92	1.35	1.04
REVB Revelation Biosciences	N/A	6.22	6.22
SKIN Beauty Health	4.36	1.76	1.48

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CRL Charles River Laboratories International	98.91%
REVB Revelation Biosciences	12.80%
SKIN Beauty Health	93.26%

Insider Ownership

Company	Insider Ownership
CRL Charles River Laboratories International	1.30%
REVB Revelation Biosciences	4.80%
SKIN Beauty Health	35.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CRL Charles River Laboratories International	19,700	47.74 million	47.12 million	Optionable
REVB Revelation Biosciences	9	3.98 million	3.79 million	Not Optionable
SKIN Beauty Health	613	130.14 million	83.94 million	Optionable

SKIN, ACRL, REVB, and CRL Headlines

Recent News About These Companies

The Beauty Health Company (NASDAQ:SKIN) Stock Has Average Target Price of $1.38 According to Brokerages

October 3 at 2:46 AM | americanbankingnews.com

The Beauty Health Company (NASDAQ:SKIN) Receives Average Rating of "Hold" from Brokerages

October 3 at 2:13 AM | marketbeat.com

Meet The Winners of The 2026 Women’s Health Skincare Awards

October 1 at 8:43 AM | womenshealthmag.comW

e.l.f. Beauty (NYSE:ELF) versus Beauty Health (NASDAQ:SKIN) Financial Comparison

October 1 at 5:14 AM | americanbankingnews.com

SkinHealth Systems Expands SkinStylus® SteriLock® MicroSystem to Europe

October 1 at 3:00 AM | globenewswire.com

J-Beauty Beginner’s Guide To Skin Longevity

September 30, 2026 | refinery29.comR

Yogurt Has Skin and Gut Health Benefits—but Only If You Choose the Right Kind

September 30, 2026 | msn.com

I served as an instructor for a 'Skincare Seminar'! Beauty and health from the perspective of UV protection

September 30, 2026 | note.comN

A beginner’s guide to K-beauty, J-beauty, and I-beauty

September 30, 2026 | msn.com

Reviewing Niagen Bioscience (NASDAQ:NAGE) & Beauty Health (NASDAQ:SKIN)

September 29, 2026 | americanbankingnews.com

What does beauty mean to me?

September 26, 2026 | note.comN

The Best Face Wash for Your Skin Type, According to Experts

September 25, 2026 | womenshealthmag.comW

Regina Skin Medical Introduces Preventive Medical Beauty Methodology Following Long-Term Skin Metabolism Studies

September 23, 2026 | manilatimes.netM

Everyday Beauty Tips for Healthy, Glowing Skin

September 23, 2026 | irishcentral.comI

Microbiome Beauty: How Pomella® Supports Skin Health

September 23, 2026 | nutraingredients.comN

Beauty is more than just appearance. How to create "beauty" by thinking from the perspective of health

September 23, 2026 | note.comN

[Beauty Vitamin] Does Vitamin B2 Support the Foundation of Your Skin? Understanding the Relationship Between Lipid Metabolism and Skin Roughness

September 22, 2026 | note.comN

dsm-firmenich Beauty & Care advances epidermal science at IFSCC Congress 2026 with CORNEOCARE™ 2.0

September 21, 2026 | finance.yahoo.com

The 8 Most Innovative Beauty Tools of the Year

September 16, 2026 | harpersbazaar.comH

Karmic Beauty on skin longevity, simpler routines and why hero ingredients may not be enough for health

September 16, 2026 | msn.com

H2Glow Launches Daily Beauty Hydration Electrolyte Drink Mix to Support Healthy Skin from Within

September 15, 2026 | bevnet.comB

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN, ACRL, REVB, and CRL Company Descriptions

Charles River Laboratories International NYSE:CRL

$290.32 +3.49 (+1.22%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$292.50 +2.18 (+0.75%)

As of 10/2/2026 08:00 PM Eastern

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Revelation Biosciences NASDAQ:REVB

$0.76 -0.04 (-4.67%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$0.81 +0.05 (+6.34%)

As of 10/2/2026 07:30 PM Eastern

Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.

Beauty Health NASDAQ:SKIN

$0.63 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$0.62 -0.01 (-1.27%)

As of 10/2/2026 05:39 PM Eastern

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SKIN, ACRL, REVB, and CRL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SKIN, ACRL, REVB, and CRL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SKIN, ACRL, REVB, and CRL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN, ACRL, REVB, and CRL Company Descriptions

Charles River Laboratories International NYSE:CRL

Revelation Biosciences NASDAQ:REVB

Beauty Health NASDAQ:SKIN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SKIN, ACRL, REVB, and CRL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SKIN, ACRL, REVB, and CRL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SKIN, ACRL, REVB, and CRL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

SKIN, ACRL, REVB, and CRL Company Descriptions

Charles River Laboratories International NYSE:CRL

Revelation Biosciences NASDAQ:REVB

Beauty Health NASDAQ:SKIN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools